MBP and myeloid sarcoma: By contrast, because Hsp70 can act as an adjuvant Hsp70–myelin basic protein (MBP) and Hsp70–proteolipid protein (PLP) complexes have been found in MS lesions, which have been considered highly immunogenic [19], [27], [28].